| "Oscillaria caviae" Simons 1920, according to Simons 1922| Oscillaria caviae| Oscillospira guillermondi| Oscillospira guillermondii| Oscillospira guilliermondii| Oscillospira guilliermondii corrig. Chatton and Perard 1913
Butyrate Production: Some members of the Oscillospira genus have been associated with the production of short-chain fatty acids (SCFAs), particularly butyrate. Butyrate is known for its potential benefits in maintaining gut health, as it serves as a key energy source for colonocytes and has anti-inflammatory properties.
Correlation with Diet: The abundance of Oscillospira in the gut microbiota has been reported to correlate with dietary factors, such as fiber intake. Diets rich in fiber are associated with diverse and beneficial gut microbial communities.
Potential Links to Metabolic Health: Some studies have explored associations between the abundance of Oscillospira and metabolic health parameters. However, the nature of these associations is complex and may be influenced by various factors.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 0.53 | 47 | 33369 | 0 | 21777 | 3066 | 312 | 9546.3 | 47 | 33369 | 7.1 %ile | 85.7 %ile | ||
biomesight | 80.13 | 0 | 140 | 10 | 200 | 0 | 890 | 160.1 | 90 | 372.4 | 10 | 230 | 0 %ile | 90.8 %ile |
thryve | 0.09 | 0 | 50 | 50 | 50 | 50 | 50 | 0 %ile | 99 %ile | |||||
ubiome | 16.1 | 0 | 34 | 22 | 2755 | 0 | 1457 | 425.9 | 200 | 526 | 0 | 962 | 0 %ile | 100 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
BiomeSight | 85.615 % | 0.017 % | 0.053 % | 2452.0 | 2864 |
custom | 3.39 % | 1.671 % | 2.355 % | 2.0 | 59 |
Medivere | 100 % | 0.023 % | 0.017 % | 7.0 | 7 |
SequentiaBiotech | 8.333 % | 0.059 % | 0.03 % | 3.0 | 36 |
Thryve | 0.145 % | 0.006 % | 0.002 % | 2.0 | 1383 |
uBiome | 16.162 % | 0.042 % | 0.052 % | 128.0 | 792 |
Click on Impact for information if high or low levels are causing the impact
Magnitude | Impact | Symptom |
---|
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.